Dihydroergotamine Mesylate
NDC Package 69238-1606-8
Package Information
Dihydroergotamine Mesylate is a medication used to treat migraine headache attacks. Marketed by Amneal Pharmaceuticals Ny Llc, this product is identified by NDC 69238-1606 and is authorized under FDA application ANDA214105.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 69238 - Amneal Pharmaceuticals Ny Llc
- 69238-1606 - Dihydroergotamine Mesylate
- 69238-1606-8 - 8 VIAL in 1 CARTON / 1 mL in 1 VIAL (69238-1606-1)
- 69238-1606 - Dihydroergotamine Mesylate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69238-1606-8 identifies a specific commercial package of 8 vial in 1 carton / 1 ml in 1 vial (69238-1606-1) of Dihydroergotamine Mesylate, labeled by Amneal Pharmaceuticals Ny Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Amneal Pharmaceuticals Ny Llc on January 10, 2022. The current certification is valid through January 14, 2026.
What are the primary indications for this medication?
This medication is used to treat migraine headache attacks. It helps relieve headache pain and other symptoms such as sensitivity to light or sound. Prompt treatment allows you to get back to your normal routine sooner and may decrease your need for other pain medications. This medication is not used to prevent migraines from occurring. Dihydroergotamine belongs to a class of drugs known as ergot alkaloids. It may work by narrowing the blood vessels in the brain. It may also block other pain pathways in the brain.
How is this Amneal Pharmaceuticals Ny Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69238160608. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.